Medication info
Clopielt Tablet (Clopidogrel Sulfate)

Clopielt Tablet (Clopidogrel Sulfate)

Prescription medicationTablet
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Shinshin Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201601120 · Approved 2016.02.26 · Insurance code 643803250

Summary

Main use
Relief of symptoms of acute coronary syndrome and atherosclerosis; prevention of thromboembolism in atrial fibrillation
Who uses it
Adults
Adult dosage
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the first day with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this medication once daily. 3. For patients with atrial fibrillation, administer this medication 75 mg orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this medication once daily. ○ Patients with renal impairment: Experience with treatment in patients with renal impairment is limited. ○ Patients with hepatic impairment: Experience with treatment in patients with moderate liver disease and bleeding diathesis is limited. This medication may be administered without regard to food.

Ingredients

Manufacturer
Shinshin Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of symptoms of acute coronary syndrome and atherosclerosis; prevention of thromboembolism in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral arterial disease
  • acute coronary syndrome
  • unstable angina
  • non-ST-elevation myocardial infarction
  • cardiovascular abnormalities
  • stroke
  • refractory ischemia
  • vascular risk factors
  • atrial fibrillation.
View approved original text

This medication is used to improve atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction, or peripheral arterial disease. Additionally, it helps alleviate atherosclerotic symptoms such as cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome (unstable angina or non-ST-elevation myocardial infarction) who undergo drug treatment or coronary interventions, including coronary artery bypass surgery. Furthermore, it reduces the risk of ischemic stroke and thromboembolism in adults with atrial fibrillation who have vascular risk factors and for whom vitamin K antagonists are not appropriate and have a low risk of bleeding. Therefore, this medication is effectively used for the improvement of various cardiovascular diseases and for reducing risk.

Dosage and Administration

Adult dosage

○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the first day with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this medication once daily. 3. For patients with atrial fibrillation, administer this medication 75 mg orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this medication once daily. ○ Patients with renal impairment: Experience with treatment in patients with renal impairment is limited. ○ Patients with hepatic impairment: Experience with treatment in patients with moderate liver disease and bleeding diathesis is limited. This medication may be administered without regard to food.

Precautions

This medication prevents the clumping of platelets in the blood, thereby preventing clots from forming. People who have a genetic reduction in the enzyme CYP2C19 that activates the drug in the liver may have diminished effectiveness of this medication; in such cases, it is advisable to consult a doctor to adjust the treatment method. Additionally, taking this medication along with drugs that increase CYP2C19 enzyme activity may raise the concentration of the active ingredient of this medication, increasing the risk of bleeding, so it is better to avoid using them together. Patients who have an allergy to this medication or its components, have bleeding issues, have severe liver dysfunction, are lactating women, or have specific genetic conditions such as lactose intolerance should not take this medication. If there is a high risk of bleeding or if bleeding-related symptoms are suspected, seek medical attention immediately, and be particularly mindful as the risk of bleeding may be heightened when combined with other antiplatelet agents or anticoagulants. Patients scheduled for surgery should stop taking this medication 5 to 7 days before the procedure and should use it with caution if they have diseases or conditions that elevate bleeding risk. During the use of this medication, it may take longer for bleeding to stop, so if wounds or bleeding areas persist, inform medical personnel immediately. Rarely, thrombocytopenia or serious blood anomalies may occur; thus, if fever or symptoms of infection appear, inform a doctor. This medication may have side effects such as gastrointestinal disturbances, headache, dizziness, and rash, with bleeding being one of the most significant side effects. Especially for the elderly, and patients with reduced kidney or liver function, the risk of bleeding may be higher, so dosing adjustments and careful monitoring according to a doctor's instructions are essential. During pregnancy, it should be used only if necessary after considering its effects on the fetus, and nursing mothers should consult with a doctor about whether to continue breastfeeding due to the potential secretion of the drug into breast milk. In case of overdose, the risk of bleeding may significantly increase, and as there is no specific antidote, immediate hospital visit for appropriate treatment is necessary. This medication should be kept out of the reach of children, and it is better not to transfer it to another container. Before taking this medication, inform your doctor or pharmacist of any other medications you are currently taking, particularly those that may raise the risk of bleeding.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius. This helps preserve the medication's efficacy and safety.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.